Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of Remdesivir (GS-5734 ™)

Source: U.S. Food and Drug Administration (FDA). Published: 5/1/2020. The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product remdesivir for treatment of suspected or laboratory confirmed coronavirus disease 2019 (COVID-19) in adults and children hospitalized with severe disease. This 36-page fact sheet provides essential information on the use of remdesivir, an unapproved drug, to treat suspected or laboratory confirmed COVID-19. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news